Singing-voice Disorders and Aerodynamic Profiles in Dysodic Singers
AeroDysodiaPro
Retrospective Study of Singing-voice Disorders and Aerodynamic Profiles in Dysodic Singers
1 other identifier
observational
100
1 country
1
Brief Summary
Singers are over-represented in phoniatric consultation; they present increased risk of developing voice disorders. They represent a specific population among phoniatric patients (specific singing-voice complaints, increased sensitivity to voice). Singing-voice disorder is called dysodia in the same way as dysphonia, which refers to speaking-voice disorders. The diagnosis of dysodia is made after a laryngeal examination and a voice assessment to identify patient's speech and singing difficulties. Most studies on prevalence of voice disorders in singers come from the American continent. Very few descriptions of this population have been made in France. Voice assessment of dysodic singers includes aerodynamic voice measurements. The use of aerodynamic measurements for the diagnosis of voice pathologies is now widely demonstrated. These parameters include measurements of estimated subglottal pressure (ESGP), phonation threshold pressure (PTP) (minimum pressure to initiate a sound) and oral airflow (OAF). They depend on the level of training of singers and the type of vocal dysfunction. Aerodynamic behaviours of dysodic singers have not yet been described, although they can help to better identify the singer's vocal difficulties and could be essential parameters for targeting more precisely rehabilitation exercises proposed in voice therapy. This study aims to describe the characteristics of a French population of singers consulting in phoniatrics and their aerodynamic behaviours. Do the singers' aerodynamic parameters (pressure, flow) reflect the dysfunctions in singing voice? Based on results of the literature on speaking and singing non-pathological voice, the investigators hypothesize that during voice assessment, ESGP values will be increased and OAF ones will be decreased over the entire vocal range of the singer in case of voice pathology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 22, 2019
CompletedFirst Posted
Study publicly available on registry
July 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedDecember 29, 2020
December 1, 2020
1.7 years
July 22, 2019
December 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Aerodynamic data : estimated subglottal pressure
estimated subglottal pressure (values in hPa)
1 day
Aerodynamic data : phonation pressure threshold
phonation pressure threshold (values in hPa)
1 day
Aerodynamic data : oral airflow rate
oral airflow rate (values in l/s).
1 day
Secondary Outcomes (9)
social and medical data : age
1 day
social and medical data : sex
1 day
social and medical data : occupation
1 day
social and medical data : singing style
1 day
social and medical data : level of training
1 day
- +4 more secondary outcomes
Eligibility Criteria
Patients who have consulted the phoniatrician (Dr Amy de la Bretèque) of the ENT department of the Gui de Chauliac hospital between January 2015 and June 2018.
You may qualify if:
- have consulted Dr Amy de la Bretèque, phoniatrist, between January 2015 and June 2018
- be a singer (professional or amateur)
- be over 18 years old
You may not qualify if:
- under 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- GIPSA-lab, Grenoble, Francecollaborator
Study Sites (1)
Uh Montpellier
Montpellier, 34295, France
Study Officials
- PRINCIPAL INVESTIGATOR
Marion BEAUD
UH MONTPELLIER
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2019
First Posted
July 30, 2019
Study Start
March 1, 2019
Primary Completion
November 1, 2020
Study Completion
June 1, 2021
Last Updated
December 29, 2020
Record last verified: 2020-12